Long-term elagolix + add-back therapy in women with endometriosis-associated pain for 48 months + 12 month post-treatment follow-up: A safety update on bone mineral density data of a phase 3 study

Authors

James A. Simon
Jin Hee Kim
James W. Thomas
Charles E. Miller, Advocate Health - MidwestFollow
Anna Chan
Michael C. Snabes

Recommended Citation

Simon JA, Kim JH, Thomas JW, Miller CE, Chan A, Snabes MC.Long-term Elagolix + add-back therapy in women with endometriosis-associated pain for 48 months + 12 month post-treatment follow-up: A safety update on bone mineral density data of a phase 3 study. Fertility and Sterility. 2024;122(4):e157. doi:10.1016/j.fertnstert.2024.07.557

Affiliations

Advocate Lutheran General Hospital

Type

Abstract